Fluoroquinolone-resistant Salmonella Paratyphi A.
Adachi
Takuya
T
Sagara
Hiroko
H
Hirose
Kenji
K
Watanabe
Haruo
H
D000368:Aged; D000369:Aged, 80 and over; D000890:Anti-Infective Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001426:Bacterial Proteins / Q000235:genetics; D002353:Carrier State / Q000188:drug therapy / Q000382:microbiology; D002939:Ciprofloxacin / Q000494:pharmacology* / Q000627:therapeutic use; D024881:Drug Resistance, Bacterial / Q000235:genetics; D005260:Female; D024841:Fluoroquinolones / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D008826:Microbial Sensitivity Tests; D010284:Paratyphoid Fever / Q000188:drug therapy* / Q000382:microbiology; D012482:Salmonella paratyphi A / Q000187:drug effects* / Q000235:genetics
D000890:Anti-Infective Agents; D001426:Bacterial Proteins; D024841:Fluoroquinolones; D002939:Ciprofloxacin
J Antimicrob Chemother. 1996 May;37(5):891-900
8737139
Clin Infect Dis. 1997 Dec;25(6):1404-10
9431387
JAMA. 1998 Feb 25;279(8):579; author reply 580
9486743
Lancet. 1998 Jan 31;351(9099):339
9652619
J Antimicrob Chemother. 1993 Sep;32(3):367-77
8262859
Lancet. 1990 Oct 27;336(8722):1065-6
1977034
Antimicrob Agents Chemother. 1999 Sep;43(9):2131-7
10471553
J Antimicrob Chemother. 2001 Nov;48(5):740-1
11679569
Emerg Infect Dis. 2000 Jul-Aug;6(4):420-1
10905982
Antimicrob Agents Chemother. 2002 Oct;46(10):3249-52
12234852